In people at risk of heart failure (HF) enrolled in the Heart 'OMics' in AGEing (HOMAGE) trial, spironolactone reduced circulating markers of collagen synthesis, natriuretic peptides, and blood pressure and improved cardiac structure and function. In the present report, we explored factors associated with dyskalaemia.

Dyskalemia in people at increased risk for heart failure. findings from the heart 'OMics' in AGEing (HOMAGE) trial / Monzo, Luca; Ferreira, João Pedro; Cleland, John G F; Pellicori, Pierpaolo; Mariottoni, Beatrice; Hazebroek, Mark R; Collier, Tim J; Cuthbert, Joe J; Pieske, Burkert; Petutschnigg, Johannes; Ahmed, Fozia Z; Girerd, Nicolas; Clark, Andrew L; Cosmi, Franco; Staessen, Jan A; Heymans, Stephane; Rossignol, Patrick; Zannad, Faiez. - In: ESC HEART FAILURE. - ISSN 2055-5822. - 9:6(2022), pp. 4352-4357. [10.1002/ehf2.14086]

Dyskalemia in people at increased risk for heart failure. findings from the heart 'OMics' in AGEing (HOMAGE) trial

Monzo, Luca
Primo
;
2022

Abstract

In people at risk of heart failure (HF) enrolled in the Heart 'OMics' in AGEing (HOMAGE) trial, spironolactone reduced circulating markers of collagen synthesis, natriuretic peptides, and blood pressure and improved cardiac structure and function. In the present report, we explored factors associated with dyskalaemia.
2022
heart failure prevention; hyperkalaemia; hypokalaemia; steroidal mineralocorticoid receptor antagonist
01 Pubblicazione su rivista::01a Articolo in rivista
Dyskalemia in people at increased risk for heart failure. findings from the heart 'OMics' in AGEing (HOMAGE) trial / Monzo, Luca; Ferreira, João Pedro; Cleland, John G F; Pellicori, Pierpaolo; Mariottoni, Beatrice; Hazebroek, Mark R; Collier, Tim J; Cuthbert, Joe J; Pieske, Burkert; Petutschnigg, Johannes; Ahmed, Fozia Z; Girerd, Nicolas; Clark, Andrew L; Cosmi, Franco; Staessen, Jan A; Heymans, Stephane; Rossignol, Patrick; Zannad, Faiez. - In: ESC HEART FAILURE. - ISSN 2055-5822. - 9:6(2022), pp. 4352-4357. [10.1002/ehf2.14086]
File allegati a questo prodotto
File Dimensione Formato  
HOMAGE dyskalemia.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 253.37 kB
Formato Adobe PDF
253.37 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1652963
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact